Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The fluorescence signal of ROS was measured using a flow cytometer, employing the FITC channel
The margin profile is differentiated by product type: Oncology: 100 Cr revenue at 30-32% EBITDA margins (looking this to grow 3x) Peptides: 40% EBITDA margins- the highest-margin segment Overall: Growing rapidly while maintaining blended margins in the high teens The company is filing extensively in regulated markets (EU GMP, ANVISA) and building branded positions in semi-regulated markets
Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy
Targeting myeloid differentiation protein 2 ameliorates rheumatoid arthritis by inhibiting inflammation and ferroptosis via MAPK and NF-B signaling pathways
doi:10.5009/gnl18490 Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D, Vrcic H, Sebecic B
